Global Compound Bone Peptide for Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Compound Bone Peptide for Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Compound bone peptide preparation, wherein, the compound bone peptide preparation is produced by mixing bone peptide extracting solution and scorpion extracting solution, performing acid treatment and alkali treatment to the mixed solution in sequence, regulating the pH value of the mixed solution after the alkali treatment is performed to be neutral, and ensuring the mixed solution with neutral pH value to contact with active carbon. The compound bone peptide preparation of the invention can be produced to be small capacity injection and freeze-dried powder injection. Compared with the prior method that the bone peptide extracting solution and the scorpion extracting solution are respectively and singly treated and then mixed, the compound bone peptide preparation provided by the invention is produced through acid precipitation, alkali precipitation and active carbon adsorption to the mixed solution of the bone peptide extracting solution and the scorpion extracting solution, can effectively remove impurity generated through the interaction because of the mixing of the bone peptide extracting solution and the scorpion extracting solution, and thereby obviously improving the clarity and reducing the injection irritability of the compound bone peptide preparation (namely improving the injection compliance).
Compound Bone Peptide for Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Compound Bone Peptide for Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Rheumatism and Rheumatoid Arthritis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Compound Bone Peptide for Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Compound Bone Peptide for Injection key manufacturers include Jiangshi Pharma, Zhitong Biopharma and Xinbai Pharmaceutical, etc. Jiangshi Pharma, Zhitong Biopharma, Xinbai Pharmaceutical are top 3 players and held % sales share in total in 2022.
Compound Bone Peptide for Injection can be divided into Intramuscular Injection and Intravenous Drip, etc. Intramuscular Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Compound Bone Peptide for Injection is widely used in various fields, such as Rheumatism, Rheumatoid Arthritis, Osteoporosis and Cervical spondylosis, etc. Rheumatism provides greatest supports to the Compound Bone Peptide for Injection industry development. In 2022, global % sales of Compound Bone Peptide for Injection went into Rheumatism filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Compound Bone Peptide for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Jiangshi Pharma
Zhitong Biopharma
Xinbai Pharmaceutical
Segment by Type
Intramuscular Injection
Intravenous Drip
Rheumatism
Rheumatoid Arthritis
Osteoporosis
Cervical spondylosis
Post-fracture healing
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Compound Bone Peptide for Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Compound Bone Peptide for Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Compound Bone Peptide for Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Compound Bone Peptide for Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Compound Bone Peptide for Injection introduction, etc. Compound Bone Peptide for Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Compound Bone Peptide for Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Compound Bone Peptide for Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Compound Bone Peptide for Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Rheumatism and Rheumatoid Arthritis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Compound Bone Peptide for Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Compound Bone Peptide for Injection key manufacturers include Jiangshi Pharma, Zhitong Biopharma and Xinbai Pharmaceutical, etc. Jiangshi Pharma, Zhitong Biopharma, Xinbai Pharmaceutical are top 3 players and held % sales share in total in 2022.
Compound Bone Peptide for Injection can be divided into Intramuscular Injection and Intravenous Drip, etc. Intramuscular Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Compound Bone Peptide for Injection is widely used in various fields, such as Rheumatism, Rheumatoid Arthritis, Osteoporosis and Cervical spondylosis, etc. Rheumatism provides greatest supports to the Compound Bone Peptide for Injection industry development. In 2022, global % sales of Compound Bone Peptide for Injection went into Rheumatism filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Compound Bone Peptide for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Jiangshi Pharma
Zhitong Biopharma
Xinbai Pharmaceutical
Segment by Type
Intramuscular Injection
Intravenous Drip
Segment by Application
Rheumatism
Rheumatoid Arthritis
Osteoporosis
Cervical spondylosis
Post-fracture healing
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Compound Bone Peptide for Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Compound Bone Peptide for Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Compound Bone Peptide for Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Compound Bone Peptide for Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Compound Bone Peptide for Injection introduction, etc. Compound Bone Peptide for Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Compound Bone Peptide for Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices